Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141891 |
| CAS No | NA |
| Mol.F. | C28H19N5O9 |
| Mol.Wt. | 569.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141892 |
| CAS No | NA |
| Mol.F. | C25H19N5O6 |
| Mol.Wt. | 485.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141893 |
| CAS No | NA |
| Mol.F. | C33H27N7O9 |
| Mol.Wt. | 665.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141894 |
| CAS No | NA |
| Mol.F. | C26H21N5O6 |
| Mol.Wt. | 499.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141895 |
| CAS No | NA |
| Mol.F. | C32H42ClN3O16 |
| Mol.Wt. | 760.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141896 |
| CAS No | NA |
| Mol.F. | C30H33ClN4O9 |
| Mol.Wt. | 629.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141897 |
| CAS No | NA |
| Mol.F. | C24H28ClN3O10 |
| Mol.Wt. | 553.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141898 |
| CAS No | NA |
| Mol.F. | C21H26ClN3O6 |
| Mol.Wt. | 451.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141899 |
| CAS No | NA |
| Mol.F. | C19H22ClN3O6 |
| Mol.Wt. | 423.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141900 |
| CAS No | NA |
| Mol.F. | C20H21ClN2O6 |
| Mol.Wt. | 420.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141901 |
| CAS No | NA |
| Mol.F. | C25H30ClN3O10 |
| Mol.Wt. | 568.0 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141902 |
| CAS No | NA |
| Mol.F. | C20H24ClN3O6 |
| Mol.Wt. | 437.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141903 |
| CAS No | NA |
| Mol.F. | C20H26ClN3O6 |
| Mol.Wt. | 439.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141904 |
| CAS No | NA |
| Mol.F. | C31H29N9O5 |
| Mol.Wt. | 607.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141905 |
| CAS No | NA |
| Mol.F. | C18H20N6O3 |
| Mol.Wt. | 368.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141906 |
| CAS No | NA |
| Mol.F. | C14H15N3O3 |
| Mol.Wt. | 273.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |